Abstract
In a controlled double-blind trial five patients with the nephrotic syndrome due to idiopathic membranous glomerulonephritis received azathioprine, 2.5 mg/kg-d, while four others received placebo. After 1 year of treatment there was no significant difference between the two groups with regard to the changes in leukocyte count, values for hemoglobin, serum creatinine, blood urea nitrogen or serum albumin, 24-hour excretion of protein in the urine, or creatinine clearance. In this study azathiprine appeared not to be useful in the treatment of idiopathic membranous glomerulonephritis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Black D. A., Rose G., Brewer D. B. Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J. 1970 Aug 22;3(5720):421–426. doi: 10.1136/bmj.3.5720.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DIXON F. J., FELDMAN J. D., VAZQUEZ J. J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1;113:899–920. doi: 10.1084/jem.113.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donadio J. V., Jr, Holley K. E., Anderson C. F., Taylor W. F. Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. Kidney Int. 1974 Dec;6(6):431–439. doi: 10.1038/ki.1974.129. [DOI] [PubMed] [Google Scholar]
- Laver M. C., Kincaid-Smith P. The natural history and treatment of membranous glomerulonephritis. Perspect Nephrol Hypertens. 1973;1(Pt 1):461–472. [PubMed] [Google Scholar]
- Row P. G., Cameron J. S., Turner D. R., Evans D. J., White R. H., Ogg C. S., Chantler C., Brown C. B. Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med. 1975 Apr;44(174):207–239. [PubMed] [Google Scholar]